16 – 30 of 86
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Achieving the unimaginable : Health equity in haemophilia
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis–an external quality assessment workshop
(
- Contribution to journal › Article
-
Mark
Factor VIII : Long-established role in haemophilia A and emerging evidence beyond haemostasis
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis : Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network
(
- Contribution to journal › Article
-
Mark
Defining extended half-life rFVIII-A critical review of the evidence
(
- Contribution to journal › Article
-
Mark
Haemophilia B : Where are we now and what does the future hold?
(
- Contribution to journal › Scientific review
-
Mark
Social and economic burden of recurrent urinary tract infections and quality of life : a patient web-based study (GESPRIT)
(
- Contribution to journal › Article
- 2017
-
Mark
Effect of late prophylaxis in hemophilia on joint status : A randomized trial
(
- Contribution to journal › Article
-
Mark
Higher risk of revision for infection using systemic clindamycin prophylaxis than with cloxacillin : A report from the Swedish Knee Arthroplasty Register on 78,000 primary total knee arthroplasties for osteoarthritis
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in haemophilia care : Guideline update 2016
(
- Contribution to journal › Article
- 2016
-
Mark
Aspects of prophylactic treatment of hemophilia
(
- Contribution to journal › Scientific review
-
Mark
Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
(
- Contribution to journal › Letter
-
Mark
Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products
(
- Contribution to journal › Article
-
Mark
Haemophilia treatment in 2030
(
- Contribution to journal › Article
- 2015
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review